Enquiry Now
Loading...
| A02418 | Pages: NA | Aug 2021 | 4020 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Selected Reaction Monitoring Market
Request Now !Selected reaction monitoring method is the highly selective and sensitive method for the quantification of protein and peptide in a complex biological sample during mass spectrometry.
It uses mass spectroscopy, which specifically targets and detects the required proteins and specifically look for peptides and protein fragments of interest. Increase in R&D in the field of biology is expected to drive the market during the analysis period. However, selected reaction monitoring process is time consuming and hence anticipated to inhibit the growth of the market.
The market is segmented based on assay type, application, end users, and geography. By assay type, it is categorized into custom assay, human discovery assay, human cancer assay, and human cardiovascular assay.
By application, it is bifurcated into biomarker assessment and MRM-MS quality control. By end users, it is divided into hospitals, diagnostic centers, and research institutes. By geography, it is studied across North America, Europe, Asia Pacific, and LAMEA.
Key Benefits
List of players profiled in the report
List of other players (These companies are not profiled in the report and same can be done on demand)
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities
CHAPTER 4 SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CUSTOM ASSAY
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. HUMAN DISCOVERY ASSAY
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. HUMAN CANCER ASSAY
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. HUMAN CARDIOVASCULAR ASSAY
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 SELECTED REACTION MONITORING, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. BIOMARKER ASSESSMENT
5.2.1. Market size and forecast
5.3. MRM-MS QUALITY CONTROL
5.3.1. Market size and forecast
5.3.2. PLATFORM PERFORMANCE
5.3.2.1. Market size and forecast
5.3.3. WORKFLOW PERFORMANCE
5.3.2.2. Market size and forecast
CHAPTER 6 SELECTED REACTION MONITORING MARKET, BY END USE
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. DIAGNOSTIC CENTRES
6.3.1. Market size and forecast
6.4. RESEARCH INSTITUTES
6.4.1. Market size and forecast
CHAPTER 7 SELECTED REACTION MONITORING MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.2.4. North America Selected Reaction Monitoring Market by Assay Type
7.2.5. North America Selected Reaction Monitoring Market by Application
7.2.6. North America Selected Reaction Monitoring Market by End-User
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.3.4. Europe Selected Reaction Monitoring Market by Assay Type
7.3.5. Europe Selected Reaction Monitoring Market by Application
7.3.6. Europe Selected Reaction Monitoring Market by End-User
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast
7.4.4. Asia-Pacific Selected Reaction Monitoring Market by Assay Type
7.4.5. Asia-Pacific Selected Reaction Monitoring Market by Application
7.4.6. Asia-Pacific Selected Reaction Monitoring Market by End-User
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Latin America market size and forecast
7.5.3.2. Middle East market size and forecast
7.5.3.3. Africa market size and forecast
7.5.4. LAMEA Selected Reaction Monitoring Market by Assay Type
7.5.5. LAMEA Selected Reaction Monitoring Market by Application
7.5.6. LAMEA Selected Reaction Monitoring Market by End-User
CHAPTER 8 COMPANY PROFILES
8.1. MRM PROTEOMICS
8.1.1. Operating business segments
8.1.3. Business performance
8.1.3. Key strategic moves and developments
8.3. SIGMA ALDRICH
8.3.1. Operating business segments
8.3.3. Business performance
8.3.3. Key strategic moves and developments
8.3. THERMO FISHER SCIENTIFIC
8.3.1. Operating business segments
8.3.3. Business performance
8.3.3. Key strategic moves and developments
8.4. ALPHALYSE
8.4.1. Operating business segments
8.4.3. Business performance
8.4.3. Key strategic moves and developments
8.5. PROTEOMICS
8.5.1. Operating business segments
8.5.3. Business performance
8.5.3. Key strategic moves and developments
8.6. LUMINEX CORPORATION
8.6.1. Operating business segments
8.6.3. Business performance
8.6.3. Key strategic moves and developments
8.7. BECTON, DICKINSON AND COMPANY
8.7.1. Operating business segments
8.7.3. Business performance
8.7.3. Key strategic moves and developments
8.8. ILLUMINA, INC.
8.8.1. Operating business segments
8.8.3. Business performance
8.8.3. Key strategic moves and developments
8.9. BIO-RAD LABORATORIES, INC.
8.9.1. Operating business segments
8.9.3. Business performance
8.9.3. Key strategic moves and developments
8.10. QIAGEN N.V.
8.10.1. Operating business segments
8.10.3. Business performance
8.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
